Owner and operator of a biopharmaceutical company. The company develops a class of mitochondrial-targeted antioxidants for the treatment of neurodegenerative diseases.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | Completed | Out of Business | ||||
2. Grant | 15-Jun-2014 | 00000 | Completed | Startup | ||
1. Accelerator/Incubator | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Janet Leeds | Chief Executive Officer | ||
Cynthia McMurray | Co-Founder | ||
Peter Wipf | Co-Founder |